2015-07-19 19:07:54 UTC

Grant Winner Looks to Further IBD Research

May 19, 2015

Clara Abraham, MD, will focus on the roles of PRRs, cytokine regulation and JAK pathways in IBD.

Clara Abraham, MD, of Yale University in New Haven, CT, recieved the 2015 American Gastroenterological Association-Pfizer JAK IBD Research Grant.

Dr. Abraham will focus her grant research on pattern recognition receptors (PRRs), cytokine regulation and JAK pathways, which all play a critical role in IBD. 

"IBD is characterized by dysregulated intestinal cytokines. In intestinal tissues, pattern recognition receptors (PRRs) on myeloid-derived cells mediate host responses to microbes," Dr. Abraham said.

"The studies proposed in this award are expected to enhance our understanding of the contribution of JAK-associated cytokine signaling pathways in regulating PRR responses in the distinct states and myeloid cell subsets within the intestine, and therefore, our ability to target these pathways in IBD," Dr. Abraham added. 

Dr. Abraham is honored to receive the grant from the AGA Research Foundation and Pfizer. 

More on Crohn's Disease

Crohn's & Colitis Congress™ (A Partnership of the Crohn's & Colitis Foundation and American Gastroenterological Association)

Jan. 18, 2018

Expand your knowledge, network with IBD leaders, spark innovative research and get inspired to improve patient care.

Putting Patients First: Digital Health Tools to Empower IBD Patients

Jan. 18, 2018

Discover how advances in digital health can help you monitor and support IBD patients remotely and dynamically, improve face-to-face care, and drive clinical decisions through shared decision-making.

Get Your Questions Answered on Biosimilar Therapies

Dec. 7, 2017

Join inflammatory bowel disease (IBD) experts on Dec. 11, 2017, 8-8:45 p.m. ET, for a free webinar on biosimilar therapies.